Back to Research Hub
BioXcel Therapeutics, Inc.
BTAI
$1.07-0.04 (-3.17%)
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology.
StreetsValue research for BioXcel Therapeutics, Inc. (BTAI)
Members get the full report for BioXcel Therapeutics, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.